Results 241 to 250 of about 36,139 (254)
Some of the next articles are maybe not open access.

Biochemistry of Coenzyme Q10

2016
Human coenzyme Q (CoQ10) or ubiquinone is mainly known for its bioenergetic role as a proton and electron carrier in the inner mitochondrial membrane and is also an endogenous lipophilic antioxidant, ubiquitous in biological membranes. It is also present in plasma lipoproteins, where it plays a well-recognized antioxidant role.
Francesca Brugè   +2 more
openaire   +2 more sources

Coenzyme Q10: A Review

Hospital Pharmacy, 2001
Coenzyme Q10 (CoQ10) is a provitamin manufactured by the body. It functions as a coenzyme for mitochondrial enzymes. It has been shown to be deficient in patients with cardiovascular disease, cancer, Acquired Immune Deficiency Syndrome (AIDS), muscular dystrophy, spontaneous abortion, male infertility, and periodontal disease.
openaire   +2 more sources

Deficiency of coenzyme Q10 in hypertensive rats and reduction of deficiency by treatment with coenzyme Q10

Biochemical and Biophysical Research Communications, 1974
Summary Rats which were unilaterally nephrectomized and treated with deoxycorticosterone acetate and saline developed hypertension, and had an increased heart weight. Treatment of these rats with coenzyme Q10 effected a lower level of hypertension and normalized the heart weight.
C. Gunnar Blomqvist   +3 more
openaire   +3 more sources

Clinical aspects of coenzyme Q10: an update

Current Opinion in Clinical Nutrition & Metabolic Care, 2005
Coenzyme Q10 is administered for an ever-widening range of disorders, therefore it is timely to illustrate the latest findings with special emphasis on areas in which this therapeutic approach is completely new. These findings also give further insight into the biochemical mechanisms underlying clinical involvement of coenzyme Q10.Cardiovascular ...
Gian Paolo Littarru, Luca Tiano
openaire   +5 more sources

Coenzyme Q10 and SAMS

2020
Statins inhibit 3-hydroxy-3-methylglutaryl coenzyme A reductase, thereby reducing production of farnesyl pyrophosphate, an intermediate in the mevalonate pathway. The mevalonate pathway ultimately produces both cholesterol and coenzyme Q10 (CoQ10), a protein important for mitochondrial function.
openaire   +2 more sources

Coenzyme Q10 in Neurodegenerative Diseases

Current Medicinal Chemistry, 2003
Coenzyme Q(10) (ubiquinone), which serves as the electron acceptor for complexes I and II of the mitochondrial electron transport chain and also acts as an antioxidant, has the potential to be a beneficial agent in neurodegenerative diseases in which there is impaired mitochondrial function and/or excessive oxidative damage.
openaire   +3 more sources

Coenzyme Q10 (Ubiquinone, Ubidecarenone)

2003
Moore and colleagues identified coenzyme Q10 in 1940 (Greenberg and Frishman, 1988). In 1957, coenzyme Q10 was isolated from beef heart by Dr. Frederick Crane. Karl Folkers, a scientist at Merck Sharpe and Dohme, elucidated its chemical formula the following year. In 1972, Dr. Folkers and an Italian researcher identified a deficiency of coenzyme Q10 in
Timothy S. Tracy, Melanie Johns Cupp
openaire   +2 more sources

Statins and coenzyme Q10

The Lancet, 2003
CJ Ellis, Russell S. Scott
openaire   +3 more sources

Coenzyme Q10

American Journal of Health-System Pharmacy, 1999
openaire   +2 more sources

The Synthesis of Coenzyme Q10

Current Organic Chemistry, 2017
Luo Meng   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy